Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
MRX Stock Forecast 2025-2026
$34.21
Current Price
$2.45B
Market Cap
Buy 8
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to MRX Price Targets
+69.5%
To High Target of $58.00
+46.2%
To Median Target of $50.00
+5.2%
To Low Target of $36.00
MRX Price Momentum
+2.0%
1 Week Change
+14.3%
1 Month Change
+20.7%
1 Year Change
+9.8%
Year-to-Date Change
-30.7%
From 52W High of $49.34
+25.1%
From 52W Low of $27.36
📊 TOP ANALYST CALLS
Did MRX Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Marex is one of their latest high-conviction picks.
Latest MRX Stock Price Targets & Analyst Predictions
Based on our analysis of 9 Wall Street analysts, MRX has a bullish consensus with a median price target of $50.00 (ranging from $36.00 to $58.00). The overall analyst rating is Strong Buy (8.9/10). Currently trading at $34.21, the median forecast implies a 46.2% upside. This outlook is supported by 8 Buy, 1 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Kyle Voigt at Keefe, Bruyette & Woods, suggesting a 5.2% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MRX Analyst Ratings
8
Buy
1
Hold
0
Sell
MRX Price Target Range
Low
$36.00
Average
$50.00
High
$58.00
Current: $34.21
Latest MRX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MRX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 7, 2025 | Goldman Sachs | Alexander Blostein | Buy | Maintains | $52.00 |
| Nov 7, 2025 | Barclays | Benjamin Budish | Overweight | Maintains | $43.00 |
| Oct 8, 2025 | Barclays | Benjamin Budish | Overweight | Maintains | $40.00 |
| Aug 14, 2025 | Barclays | Benjamin Budish | Overweight | Maintains | $50.00 |
| Jun 9, 2025 | Barclays | Benjamin Budish | Overweight | Maintains | $52.00 |
| May 16, 2025 | Goldman Sachs | Alexander Blostein | Buy | Maintains | $48.00 |
| May 16, 2025 | Keefe, Bruyette & Woods | Kyle Voigt | Outperform | Maintains | $54.00 |
| Apr 7, 2025 | Barclays | Benjamin Budish | Overweight | Maintains | $44.00 |
| Apr 3, 2025 | Goldman Sachs | Alexander Blostein | Buy | Maintains | $44.00 |
| Mar 7, 2025 | Barclays | Benjamin Budish | Overweight | Maintains | $43.00 |
| Mar 7, 2025 | Goldman Sachs | Alexander Blostein | Buy | Maintains | $40.00 |
| Jan 13, 2025 | Barclays | Benjamin Budish | Overweight | Maintains | $39.00 |
| Jan 7, 2025 | Piper Sandler | Patrick Moley | Overweight | Maintains | $40.00 |
| Dec 20, 2024 | Keefe, Bruyette & Woods | Kyle Voigt | Outperform | Maintains | $36.00 |
| Dec 9, 2024 | Barclays | Benjamin Budish | Overweight | Maintains | $35.00 |
| Nov 21, 2024 | HSBC | Carlos Gomez-Lopez | Buy | Initiates | $33.00 |
| Nov 8, 2024 | Piper Sandler | Patrick Moley | Overweight | Maintains | $32.00 |
| Nov 8, 2024 | Keefe, Bruyette & Woods | Kyle Voigt | Outperform | Maintains | $33.00 |
| Nov 8, 2024 | Barclays | Benjamin Budish | Overweight | Maintains | $32.00 |
| Nov 6, 2024 | Citigroup | Chris Allen | Buy | Reinstates | $34.00 |
Marex Group plc (MRX) Competitors
The following stocks are similar to Marex based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Marex Group plc (MRX) Financial Data
Marex Group plc has a market capitalization of $2.45B with a P/E ratio of 9.9x. The company generates $2.67B in trailing twelve-month revenue with a 10.5% profit margin.
Revenue growth is +72.9% quarter-over-quarter, while maintaining an operating margin of +14.0% and return on equity of +27.0%.
Valuation Metrics
Market Cap
$2.45B
Enterprise Value
$2.22B
P/E Ratio
9.9x
PEG Ratio
0.4x
Price/Sales
0.9x
Growth & Margins
Revenue Growth (YoY)
+72.9%
Gross Margin
+39.7%
Operating Margin
+14.0%
Net Margin
+10.5%
EPS Growth
+25.3%
Financial Health
Cash/Price Ratio
+437.5%
Current Ratio
1.1x
Debt/Equity
886.9x
ROE
+27.0%
ROA
+0.8%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Marex Group plc (MRX) Business Model
About Marex Group plc
What They Do
Global commodities broker specializing in diverse sectors.
Business Model
Marex Group plc generates revenue by offering comprehensive brokerage services in commodities trading, including risk management, market making, and execution services for various sectors such as metals, agriculture, and energy. The company serves a diverse clientele, including institutional investors and commercial entities, and facilitates trading activities like hedging and speculation on its advanced trading platform.
Additional Information
Founded in 2005, Marex has established a significant presence in international markets, enhancing market efficiency and transparency. The firm utilizes cutting-edge technology and market insights to empower clients in making informed trading decisions.
Company Information
Sector
Financial Services
Industry
Capital Markets
Employees
2,671
CEO
Mr. Ian Theo Lowitt
Country
United Kingdom
IPO Year
2024
Website
www.marex.comMarex Group plc (MRX) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Guild Holdings Company (GHLD) Q3 Earnings and Revenues Surpass Estimates
Guild (GHLD) delivered earnings and revenue surprises of +47.06% and +5.61%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Nov 05, 2025
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
A class action lawsuit has been filed against Marex Group plc (NASDAQ: MRX) for alleged securities violations. Affected investors should contact Schall Law Firm by December 8, 2025.
Why It Matters
A class action lawsuit against Marex Group could lead to financial penalties or negative publicity, impacting stock performance and investor confidence in the company.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Levi & Korsinsky, LLP has announced a class action securities lawsuit against Marex Group plc (NASDAQ: MRX), notifying investors of the legal proceedings.
Why It Matters
A class action lawsuit against Marex Group plc may indicate potential legal and financial risks, impacting the company's stock performance and investor confidence.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Investors in Marex Group plc (NasdaqGS: MRX) have until December 8, 2025, to file lead plaintiff applications in a securities class action for purchases made between May 16, 2024, and August 5, 2025.
Why It Matters
A class action lawsuit against Marex Group plc could lead to financial liabilities, affecting stock performance and investor confidence during the specified class period.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
A class action lawsuit has been filed against Marex Group plc (NASDAQ: MRX) for alleged securities fraud affecting investors from May 16, 2024, to August 5, 2025.
Why It Matters
The class action lawsuit against Marex Group plc signals potential financial liability, which may negatively impact stock prices and investor confidence.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Investors in Marex Group plc (NASDAQ: MRX) who suffered losses may explore potential recovery options under federal securities laws. More information is available via the provided link.
Why It Matters
The news indicates potential legal issues for Marex Group plc, which could lead to financial losses for investors, prompting them to assess their investments and potential recovery options.
Source: Newsfile Corp
Market Sentiment:
Neutral
Quick Summary
Marex Group PLC (NASDAQ: MRX) faces a class action for allegedly misleading investors on revenue projections during the period of August 14, 2024, to August 5, 2025.
Why It Matters
The class action against Marex Group highlights potential financial mismanagement, which could lead to stock price volatility and impact investor confidence significantly.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About MRX Stock
What is Marex Group plc's (MRX) stock forecast for 2026?
Based on our analysis of 9 Wall Street analysts, Marex Group plc (MRX) has a median price target of $50.00. The highest price target is $58.00 and the lowest is $36.00.
Is MRX stock a good investment in 2026?
According to current analyst ratings, MRX has 8 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $34.21. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MRX stock?
Wall Street analysts predict MRX stock could reach $50.00 in the next 12 months. This represents a 46.2% increase from the current price of $34.21. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Marex Group plc's business model?
Marex Group plc generates revenue by offering comprehensive brokerage services in commodities trading, including risk management, market making, and execution services for various sectors such as metals, agriculture, and energy. The company serves a diverse clientele, including institutional investors and commercial entities, and facilitates trading activities like hedging and speculation on its advanced trading platform.
What is the highest forecasted price for MRX Marex Group plc?
The highest price target for MRX is $58.00 from at , which represents a 69.5% increase from the current price of $34.21.
What is the lowest forecasted price for MRX Marex Group plc?
The lowest price target for MRX is $36.00 from Kyle Voigt at Keefe, Bruyette & Woods, which represents a 5.2% increase from the current price of $34.21.
What is the overall MRX consensus from analysts for Marex Group plc?
The overall analyst consensus for MRX is bullish. Out of 9 Wall Street analysts, 8 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $50.00.
How accurate are MRX stock price projections?
Stock price projections, including those for Marex Group plc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: November 15, 2025 3:16 PM UTC